Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A Realistic Way to Save Rainforests

01.10.2003


U of U biologists Phyllis Coley and Tom Kursar spent five years working in Panama to conserve rainforests and promote economic development by stimulating a native industry aimed at finding new medicines in rainforest plants.
Credit: Tom Kursar & Phyllis Coley


Plants develop chemical defenses to survive attackes by insects such as these grasshoppers. Those chemicals sometimes can be developed into medicines to combat human diseases.
Credit: Robin Foster, Field Museum, Chicago


Exploit Plant Defenses, Build Local Drug Discovery Industry

Misty-eyed idealism alone will not save Earth’s dwindling tropical rainforests. But a five-year, $3 million study in Panama indicates rainforests can be protected if the pharmaceutical industry establishes Third World laboratories and hires local researchers to look for new medicines extracted from plants that evolved defenses against insects.

“Until now, efforts to find drugs in the rainforest haven’t really led to rainforest conservation,” says Tom Kursar, an associate professor of biology at the University of Utah, who led the study with his wife, biology Professor Phyllis Coley. “But we have developed a novel approach that provides a direct link between looking for drugs and promoting conservation and economic development in biodiversity-rich countries.”



Coley adds: “Rainforests are disappearing at a terrifying rate. Searching for drugs in the rainforests of developing countries might be one solution. In our research, not only are we finding potential pharmaceuticals, but we are contributing to conservation of the forests.”

The study was funded by $3 million in grants to Coley and colleagues through the Smithsonian Tropical Research Institute in Balboa, Panama, where they also hold appointments and spend a few months each year. The money came from the National Institutes of Health, National Science Foundation and U.S. Department of Agriculture. The results were published in October’s issue of the Ecological Society of America journal Frontiers in Ecology and the Environment. The report was written by Coley, Kursar and 13 other scientists, most from the University of Panama.

Trying to save rainforests via “bioprospecting” for potential new medicines is based on the idea that developing nations will work to conserve their rainforests if nondestructive industries such as bioprospecting, ecotourism and watershed protection provide greater economic benefits than logging and ranching.

But the concept has not been particularly effective because only a small fraction of plant extracts actually are developed into drugs, and when they are, it takes years for the nation with the rainforest to start earning royalties.

“The challenge, therefore, is to provide immediate and guaranteed benefits even if royalties are not forthcoming,” the biologists wrote. “A solution becomes apparent upon recognizing that the research and development pyramid underlying the successful development of a drug is based on many basic but essential discoveries, a tiny fraction of which result in a product.”

Worldwide drug company investment in research and development is estimated at $27 billion to $43 billion annually, and “about one-third of that is spent on research that could be carried out in developing countries,” including extraction of chemicals from rainforest plants, synthetic production of those chemicals for use as medicines, lab testing of the chemicals’ activity against disease, and testing in animals.

“If part of these huge investments by industry, governments of developed nations and nongovernmental organizations would be redirected toward bioprospecting research in the source country [the source of the plants], then biodiversity-rich countries would receive immediate and guaranteed benefits from the nondestructive use of their natural resources,” Coley, Kursar and their Panamanian colleague said in the study.

The pilot project in Panama demonstrates how that could work. The project produced benefits for Panama by establishing bioprospecting, chemical extraction and laboratory operations in the nation using local students as well as scientists who taught at local universities but who previously lacked funding to conduct research.

“By conducting all of the research in Panama, we circumvent the issue of uncertain royalties and provide immediate and lasting benefits in the form of training, employment, technology transfer and infrastructure development,” the biologists wrote.

During the past five years, the project established six laboratories in Panama and employed local citizens: 10 senior scientists, 57 paid research assistants and 12 student volunteers. Twenty Panamanian students earned bachelors degrees in the process, a dozen earned or worked on master’s degrees, and one started work on a doctorate.

The Smithsonian Tropical Research Institute and Panamanian scientists recently obtained a provisional patent for three alkaloid chemicals extracted from local plants. Tests by Panamanian scientists Luz Romero and Luis Cubilla-Rios showed the chemicals were active against the parasite that causes leishmaniasis, a potentially fatal disease caused by parasites transmitted by sand fly bites. The chemicals now are being tested in Panama on mice to determine if they are safe, and tests are just starting to determine if they are effective against leishmaniasis in animals.

Kursar says the number of plant extracts that become drugs is less important than having scientists from Panama find and develop potential drugs.

“You do the work in the host country and you are creating jobs,” Coley says. “The next step is for the country to recognize those jobs depend on the intact rainforest.”

Why should drug companies set up labs and hire staff in developing nations?

“They collaborate all the time with academic scientists and small biotech firms in the developed world,” says Coley. “If the capability exists in developing nations, such research could be done there, perhaps at a lower cost.”

In a commentary accompanying the study, Jeffrey McNeeley, chief scientist of the World Conservation Union, noted some bioprospecting efforts have been called “biopiracy,” such as when a drug company made $200 million in profits selling cancer drugs developed from Madagascar’s rosy periwinkle while that country “got nothing.”

McNeeley praised the Panama project led by Coley and Kursar as “an excellent first step” that “shows how to conduct more of the value-added bioprospecting research in the source country, and build the technical capacity of local people while doing so.”

The new study also showed how potential drugs can be found more effectively by focusing on how plants make chemicals to defend themselves against insects.

“Despite the many drugs obtained from plants in the past, success rates could be greatly improved by incorporating ecological knowledge,” the researchers wrote.

The scientists collected leaves throughout Panama’s protected wild lands, prepared extracts and tested the extracts on breast, lung and nervous system cancer cells; on the AIDS virus; and on organisms that cause three tropical diseases: malaria, leishmaniasis, and Chagas’ disease, a parasitic infection that kills 50,000 people each year. Plant extracts were considered highly active if they killed or inhibited the growth of the cancerous or infected cells without killing other cells.

The study found:
-- Chemical activity was much greater in young leaves than in older leaves because young leaves lack the toughness that older leaves use as a defense against insects. So young leaves are more likely to contain potential medicines.
-- Young leaves contain more active chemicals than older leaves, even from the same plant. The researchers tested 18 woody plant species, and found 10 of the species contained toxic chemicals called alkaloids that were present only in young leaves, not old leaves. Only three species had alkaloids in old leaves and not young leaves.
-- Plants that live in the shade are more likely to contain active chemicals than sun-loving plants. It takes longer for a shade-tolerant plant to grow new leaves to replace those eaten by insects, so the shade-tolerant plants develop stronger chemical defenses than plants that live in sunlight and can replace leaves more quickly.

The drug-hunting principles tested by Coley and Kursar in Panama were developed during years of earlier work in Africa, Southeast Asia and Panama, “and therefore should be applicable to tropical forests worldwide,” they wrote.

Phyllis Coley | University of Utah
Further information:
http://www.utah.edu/unews/releases/03/sep/medplant.html

More articles from Ecology, The Environment and Conservation:

nachricht Scientists team up on study to save endangered African penguins
16.11.2017 | Florida Atlantic University

nachricht Climate change: Urban trees are growing faster worldwide
13.11.2017 | Technische Universität München

All articles from Ecology, The Environment and Conservation >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

Im Focus: Wrinkles give heat a jolt in pillared graphene

Rice University researchers test 3-D carbon nanostructures' thermal transport abilities

Pillared graphene would transfer heat better if the theoretical material had a few asymmetric junctions that caused wrinkles, according to Rice University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

NASA detects solar flare pulses at Sun and Earth

17.11.2017 | Physics and Astronomy

NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures

17.11.2017 | Health and Medicine

The importance of biodiversity in forests could increase due to climate change

17.11.2017 | Studies and Analyses

VideoLinks
B2B-VideoLinks
More VideoLinks >>>